Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

NCT04463056 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Hemoglobinuria
Marchiafava-Micheli Syndrome
Paroxysmal Hemoglobinuria

Interventions

BIOLOGICAL: Elizaria®
BIOLOGICAL: Soliris®

Sponsor

AO GENERIUM